Riskpilot← Back to searchSign inGet full accessGungner Medical AB
ABIn liquidationOrg 5566965165Research and experimental development on natural sciences and engineering · NACE 7210Est. 20061 employees
Revenue 2025
SEK 0
EBITDA margin
—
+9% vs 2024
Equity ratio
87.3%
Financial strength
Net profit 2025
SEK 22,6M
+3266% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -42K | +9% |
| Net profit | SEK 22,6M | +3266% |
| Total assets | SEK 46,3M | +154% |
| Equity | SEK 40,4M | +124% |
| Employees | 1 | — |
Legal name
Gungner Medical AB
Org number
5566965165
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14 januari 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolagets verksamhet är att bedriva konsultverksamhet inom läkemedelsforskning och utveckling, konsultverksamhet inom event- och upplevelsebranschen, marknadskommunikation, förvaltning av fast och lös egendom, handel med värdepapper samt därmed förenlig verksamhet.
Address
Phone
+46705145453
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −56 | −51 | −37 | −46 | −42 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −56 | −51 | −37 | −46 | −42 |
| Net financials | 2 337 | 750 | 753 | 893 | 28 463 |
| Profit before tax | 2 280 | 698 | 717 | 847 | 28 421 |
| Tax | −471 | −146 | −150 | −177 | −5 859 |
| Net profit | 1 809 | 552 | 567 | 670 | 22 563 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 17 196 | 17 390 | 17 770 | 18 258 | 46 292 |
| Equity | 16 867 | 17 229 | 17 605 | 18 066 | 40 418 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 329 | 161 | 165 | 192 | 5 874 |
| Total debt | 329 | 161 | 165 | 192 | 5 874 |
EBITDA margin
-4153600.0%
This company
15.8%
Market median
-26288708% vs market
20212025
Equity ratio
87.3%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
55.8%
This company
18.4%
Market median
+203% vs market
20212025
Net profit margin
2256264000.0%
This company
8.1%
Market median
+27855111011% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2026 |
BJ External Signatory | External Signatory | 2026 |
AE External Signatory | External Signatory | 2026 |
UM External Signatory | External Signatory | 2026 |
EJ Liquidator | Liquidator | 2026 |
| Former (2) | ||
KG Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
CM | Audit | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairman | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gungner Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Anna Elisabet Viktoria Björk | External Signatory | 0 companies |
| Karl Georg Harmenberg | Chief Executive Officer | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Camilla Mariette Arfsvik | Audit | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Liquidator | 0 companies |
| Johan Georg Harmenberg | Chairman | 0 companies |
| Bo Harald Aurehl | Deputy Board Member | 0 companies |